INVA
Innoviva Inc
NASDAQ: INVA · HEALTHCARE · BIOTECHNOLOGY
$23.05
-2.70% today
Updated 2026-04-29
Market cap
$1.71B
P/E ratio
6.98
P/S ratio
4.15x
EPS (TTM)
$3.30
Dividend yield
—
52W range
$17 – $25
Volume
0.7M
WallStSmart proprietary scores
84
out of 100
Grade: A
Strong Buy
Investment rating
8.0
Growth
A7.3
Quality
B+9.0
Profitability
A+8.3
Valuation
A5/9
Piotroski F-Score
Moderate
2.2
Altman Z-Score
Grey zone
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$33.20
+44.03%
12-Month target
$27.74
+20.35%
Intrinsic (DCF)
—
Margin of safety
—
0 Strong Buy4 Buy0 Hold1 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Profit margin 65.90% — above average
+ ROE 29.10% — strong efficiency
+ Free cash flow $53.38M — positive
+ Revenue growth 24.80% QoQ
Risks
No major risks identified
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $331.34M | $310.46M | $358.71M | $425.13M | $411.33M |
| Net income | $213.92M | $179.72M | $23.39M | $271.17M | $164.15M |
| EPS | — | — | — | — | $3.30 |
| Free cash flow | $201.66M | $140.65M | $188.42M | $195.80M | $53.38M |
| Profit margin | 64.56% | 57.89% | 6.52% | 63.78% | 65.90% |
Peer comparison
Smart narrative
Innoviva Inc trades at $23.05. representing a P/E of 6.98x trailing earnings. Our Smart Value Score of 84/100 indicates the stock is excellent. The company scores 5/9 on the Piotroski F-Score. With an Altman Z-Score of 2.17, it sits in the grey zone. TTM revenue stands at $411.33M. with profit margins at 65.90%.
Frequently asked questions
What is Innoviva Inc's stock price?
Innoviva Inc (INVA) trades at $23.05.
Is Innoviva Inc overvalued?
Smart Value Score 84/100 (Grade A, Strong Buy).
What is the price target of Innoviva Inc (INVA)?
The analyst target price is $33.20, representing +44.0% upside from the current price of $23.05.
What is Innoviva Inc's revenue?
TTM revenue is $411.33M.
Piotroski F-Score?
5/9 — moderate financial health.
Altman Z-Score?
2.17 — grey zone.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio4.15x
ROE29.10%
Beta0.40
50D MA$23.03
200D MA$20.55
Shares out0.07B
Float0.07B
Short ratio—
Avg volume0.7M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—